+ 1.54
+ 0.53%
+ 0.21
+ 0.06%

Medical Cannabis Products Formulated For Autism Patients Now Available In Louisiana

October 2, 2020 2:32 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

HOPE, a line of medical cannabis tinctures for children and adults with Autism Spectrum Disorder (ASD), is now available in Louisiana cannabis pharmacies and can be sold under prescription.

The products — gluten, dairy, soy and nut-free — can be found in all nine of Louisiana’s cannabis pharmacies. They're available in two formulations: “HOPE1,” a 1:1 THC:CBD tincture, and “HOPE2”, a 5:1 THC:CBD tincture.


HOPE is the brainchild of Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education, and advocacy around medical marijuana.

The ingredients are grown, processed and packaged in Louisiana through a partnership between Ilera Holistic Healthcare and Southern University’s Agricultural Center.

This summer, The Southern University Agricultural Research and Extension Center in Baton Rouge, part of the Southern University System in Louisiana, became the nation’s first historically Black university to launch its own THC medical cannabis product line, in partnership with Ilera Holistic Healthcare, under the name AYO.

"We are thrilled to partner with Ilera Holistic Healthcare to bring HOPE™ to families affected by Autism living in Louisiana,” said Daniels. “We have patients who have started using the product, and hearing their testimonials about improvements in their quality of life brings hope that patients and families throughout the state will benefit from this groundbreaking collaboration.”

Courtesy photo

Related Articles

Jushi To Expand Scranton Facility To Create Some 100 New Jobs

Jushi Holdings Inc. read more

Mexico's Cannabis Legalization Bill Will Boost Business, But There Are Concerns

Mexican Senators approved a historic adult use cannabis legalization bill on Nov. 19, with an 82 to 18 vote. read more

IGC Commences Phase 1 Of Cannabinoid Clinical Trial For Alzheimer's Patients

India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE:IGC) announced that it is enrolling participants suffering from mild to severe dementia due to Alzheimer's disease for its Phase 1 read more

Cannabis Movers & Shakers: Elev8, Eaze, Aphria, Australis, Arcview, HempMeds, iAnthus, EnWave

Here is a summary of the latest company shakeups within the cannabis industry. Elev8 Cannabis Names Naomi Granger CFO Oregon-based adults-medical cannabis company Elev8 Cannabis tapped Naomi Granger to oversee its finance department. read more

Social Equity Measures Are Crucial On Day One Of Legalization, Cannabis Advocates Say

While the cannabis industry celebrated five states passing reform initiatives on Election Day, advocates noticed that the bills lacked key parameters to address social equity. read more